Vigne, Jonathan http://orcid.org/0000-0002-6575-9224
Bay, Sylvie
Aid-Launais, Rachida
Pariscoat, Guillaume
Rucher, Guillaume
Sénémaud, Jean
Truffier, Ariane
Anizan, Nadège
Even, Guillaume
Ganneau, Christelle
Andreata, Francesco
Le Borgne, Marie http://orcid.org/0000-0002-3439-4867
Nicoletti, Antonino
Le Guludec, Dominique
Caligiuri, Giuseppina
Rouzet, Francois http://orcid.org/0000-0001-6109-0087
Funding for this research was provided by:
Merck & Co., Inc. | Merck Sharp and Dohme (Save Brain, Save Brain, Save Brain, Save Brain, Save Brain, Save Brain, Save Brain)
Agence Nationale de la Recherche (ANR-11-INBS-0006, ANR-11-INBS-0006, ANR-11-INBS-0006)
Assistance Publique - Hôpitaux de Paris (IVASC, IVASC, IVASC, IVASC, IVASC)
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Article History
Received: 12 September 2019
Accepted: 2 December 2019
First Online: 20 December 2019
Competing interests
: Part of the data presented in this work are comprised in a recently filed patent: Inventor Sylvie Bay, Antonino Nicoletti, Dominique Le Guludec, Jonathan Vigne, Giuseppina Caligiuri; “CD31shed as a molecular target for imaging of inflammation”. PCT/EP2017/060574. No other potential conflicts of interest relevant to this article exist.